23 February, 2010
The U.S. Food and Drug Administration is reviewing data on possible heart risks with GlaxoSmithKline diabetes drug Avandia but has not reached any new conclusions. The FDA will hold a public meeting in July 2010 to discuss the risks and benefits of the Avandia, but said in the meantime doctors and patients should continue to use Avandia Continue reading FDA: No new conclusions on Glaxo's Avandia yet
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety23 February, 2010
FDA Report: Take Avandia Off the Market
Two officials from the Food and Drug Administration are recommending that diabetes drug Avandia be pulled from the market because of its potential to harm the heart, the New York Times reports. Agency reports suggest that if every diabetic taking Avandia switched to a different medication, about 500 heart attacks would be averted each month. And in the third quarter of 2009 Continue reading Avandia recall advised by FDA in report
Category: Avandia Recall